# 2026-12138: Company Seeks Permit to Import Scheduled Drugs

2026-12138, Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-06-17, effective 2026-07-17 (as of 2026-06-24).

- Canonical: https://policyrisk.com/federal-register/2026-12138
- As of: 2026-06-24
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-12138
- Title: Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 36616
- Published: 2026-06-17
- Effective: 2026-07-17
- Comments close: 2026-07-17
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-24

## In one line

Company Seeks Permit to Import Scheduled Drugs

## Summary

AndersonBrecon, Inc., also known as PCI Pharma Services, wants to become an official importer of certain controlled substances. This means they’ll be allowed to bring in specific drugs under government rules. People who make or use these drugs can share their thoughts or ask for a hearing by July 17, 2026, so keep an eye on that deadline!

## Abstract

AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-20749](https://policyrisk.com/federal-register/2026-20749): Vladimir Romaniv, P.A.; Decision and Order, 2026-10-09
- [2026-20750](https://policyrisk.com/federal-register/2026-20750): L Krenk DBA Maui Clinic Pharmacy; Decision and Order, 2026-10-09

## Sources
- [2026-12138 on federalregister.gov](https://www.federalregister.gov/documents/2026/06/17/2026-12138/importer-of-controlled-substances-application-andersonbrecon-inc-dba-pci-pharma-services)
- [2026-12138 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-06-17/pdf/2026-12138.pdf)

## Related
- [Previous: 2026-12137, Importer of Controlled Substances Application: Arizona Department of Corrections](https://policyrisk.com/federal-register/2026-12137)
- [Next: 2026-12140, Importer of Controlled Substances Application: Scottsdale Research Institute](https://policyrisk.com/federal-register/2026-12140)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-12138 (as of 2026-06-24).